Doctorat en Sciences / info:eu-repo/semantics/nonPublished

Cette thèse se donne pour but l'analyse de 159 inscriptions ottomanes relevées dans la ville de Tripoli de Libye (période 1555 - 1906). Cet ensemble épigraphique de grande valeur, quasiment inédit, permet d'éclairer l'histoire de la ville et de ses principaux représentants. Chaque inscription, monumentale ou funéraire, est étudiée d'un point de vue historique mais également matériel (décors, supports, écriture et paléographie). La langue (arabe ou parfois osmanli), le contenu et la forme font aussi l'objet d'une étude approfondie. Chaque inscription est analysée, traduite et commentée dans une fiche type (volume 1) ; les analyses des données sont regroupées dans le volume 2 ; les plans, cartes, photos et fac-similés occupent le volume 3. Ce travail met en lumière la richesse patrimoniale et épigraphique de Tripoli et de sa région et ouvre la voie à de nouvelles études et réflexions sur la Régence ottomane. / This dissertation aims at analysing 159 inscriptions from the city of western Tripoli dating from the Ottoman period (1555 - 1906). This epigraphic corpus, for the main part unpublished, stands out for his value, since it sheds more light on the history of the city and on its representatives. Each inscription, be it monumental or funeral, studied from an historical, as well as a material (decoration, media, writing and palaeography) context. The language (Arabic and sometimes Osmanli), the content and the form are thoroughly analysed. Volume 1 includes the corpus of the inscriptions, each of which is analysed, translated and annotated in a standard form. Volume 2 presents the analysis of the data. Finally, volume 3 contains the plans, maps, photos and facsimiles. This study highlights the heritage and epigraphic richness of Tripoli and its region ; it opens the way to new investigations on the Ottoman Regency.

Aim/Objectives: There were two aims; improving type II diabetes glycaemic control; and enhancing the role of community pharmacists by engaging them in type II diabetes medicine management. Methods: This quantitative study collected data from both community pharmacists and patients. In a premises survey, 426 self-administered questionnaires were distributed to community pharmacies. In a knowledge survey, 125 questionnaires were distributed to community pharmacists. In a clinical trial, 40 community pharmacies were randomly assigned to be control (18) and intervention (22) premises. Each pharmacy recruited 4 or 5 patients with type II diabetes. 225 patients were recruited and assigned to receive usual pharmacist care (n=100) or a pre-defined pharmacist intervention (n=125). Results: Community pharmacists had good knowledge of diabetes with average scores 21/29 (±3.18). The differences between control and intervention groups in patients' HbA1c and FPG changes were not significant. In the intervention group patients' diabetes knowledge was significantly improved (p=0.031). In the intervention group HbA1c and FPG improved significantly and in the control group FPG improved significantly and HbA1c did not. Patients' self-reported self-management activities improved significantly around blood glucose measurements (p < 0.001) and physical exercising (p=0.001). Attitudes around the value of tight control of diabetes improved (p < 0.001). Conclusion: The findings suggest that community pharmacists in Libya may have the ability to improve type II diabetes care. The primary outcomes were not improved in intervention versus control. The before/after analysis showed significant improvement in primary outcomes in the intervention group and also in one of the primary outcomes in the control group. Patients' self-reported self-care activities and attitudes improved significantly in the intervention group.

Aim/Objectives: There were two aims; improving type II diabetes glycaemic control; and enhancing the role of community pharmacists by engaging them in type II diabetes medicine management. Methods: This quantitative study collected data from both community pharmacists and patients. In a premises survey, 426 self-administered questionnaires were distributed to community pharmacies. In a knowledge survey, 125 questionnaires were distributed to community pharmacists. In a clinical trial, 40 community pharmacies were randomly assigned to be control (18) and intervention (22) premises. Each pharmacy recruited 4 or 5 patients with type II diabetes. 225 patients were recruited and assigned to receive usual pharmacist care (n=100) or a pre-defined pharmacist intervention (n=125). Results: Community pharmacists had good knowledge of diabetes with average scores 21/29 (±3.18). The differences between control and intervention groups in patients' HbA1c and FPG changes were not significant. In the intervention group patients' diabetes knowledge was significantly improved (p=0.031). In the intervention group HbA1c and FPG improved significantly and in the control group FPG improved significantly and HbA1c did not. Patients' self-reported self-management activities improved significantly around blood glucose measurements (p<0.001) and physical exercising (p=0.001). Attitudes around the value of tight control of diabetes improved (p<0.001). Conclusion: The findings suggest that community pharmacists in Libya may have the ability to improve type II diabetes care. The primary outcomes were not improved in intervention versus control. The before/after analysis showed significant improvement in primary outcomes in the intervention group and also in one of the primary outcomes in the control group. Patients' self-reported self-care activities and attitudes improved significantly in the intervention group.